News that has caught Rachael Babin’s eye this week
Browsing: Editor’s Choice
New immunotherapy combination shows promise for patients with advanced melanoma
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable…
Five-year Survival Rate For Nivolumab-treated Advanced Lung Cancer Patients Much Higher Than Historical Rate
Treatment with the immune checkpoint inhibitor nivolumab (Opdivo) yielded durable responses in some patients with…
Phase II trial: Rice bran adds microbiome diversity, slows growth of colon cancer cells
University of Colorado Cancer Center researchers presented the results of a phase II clinical trial…
Findings support use of less invasive hysterectomy for early-stage endometrial cancer
Researchers found similar rates of disease-free survival and no difference in overall survival among women…
Vitamin D, calcium supplements do not significantly reduce breast cancer risk among older women
Among healthy postmenopausal women, supplementation with vitamin D3 and calcium compared with placebo did not…
Toward glow-in-the-dark tumours: New fluorescent probe could light up cancer
What if you could plaster cancer cells with glowing “Here We Are” signs, so surgeons…
Exposure to BPA substitute, BPS, multiplies breast cancer cells
Bisphenol S (BPS), a substitute for the chemical bisphenol A (BPA) in the plastic industry,…
Link between common prostate cancer treatment, dementia detailed in new study
A new analysis of patients who have undergone treatment for prostate cancer shows a connection…
AACR 2017: Wearable medical device improves survival for patients with glioblastoma
Patients with glioblastoma who wore a medical device that delivers alternating electrical fields in addition…
High doses of vitamin C to improve cancer treatment passes human safety trial
Clinical trials found that it is safe to regularly infuse brain and lung cancer patients…